eli lilly phase 3 trial retatrutide said Thursday its experimental obesity drug delivered up to 28.3 percent body-weight reduction over 80 weeks in the pivotal TRIUMPH-1 trial, a result nearing the weight-loss range Remember, it is still in

Duodenal ulcers often cause burning and gnawing stomach pain

That kind of transparency mattered to me

How Much Does Mounjaro Cost Per Month in the UK

The state-by-state variability creates a geographic lottery effect

It is FDA-approved, uses SNAC absorption technology, and rides on the same clinical evidence base as injectable Wegovy

Eli Lilly Announces Positive Phase 3 Results for Retatrutide (TRIUMPH-2 & TRIUMPH-3) 23 July,2026 Eli Lilly and Company has announced positive topline results from two additional pivotal Phase 3 obesity trials, further strengthening the evidence for retatrutide, the investigational GIP/GLP-1/Glucagon triple receptor agonist